Brief: Oncolys Biopharma to jointly research on OBP-301 with Japan-based university
05/07/2016 07:10
July 5 (Reuters) - Oncolys Biopharma Inc 4588.T :
* Says it to jointly research with a research group of a
Japan-based university, regarding combinational effect of
oncolytic virus OBP-301 (Telomelysin) and checkpoint inhibitor
Source text in Japanese: https://goo.gl/LMGZPC
Further company Coverage: 4588.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))